Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Rotator Cuff Tendonitis, Bicipital Tendonitis, Subdeltoid Bursitis of the Shoulder, Subacromial Bursitis of the Shoulder, Medial Epicondylitis of the Elbow, Lateral Epicondylitis of the Elbow, DeQuervain's Tenosynovitis of the Wrist
Interventions: diclofenac sodium, Matching Placebo; Drug
Lead sponsor: Cerimon Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 308 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Tobacco Use Disorder
Interventions: nicotine transdermal system, bupropion, Medication Management, Mayo Counseling, placebo patch, placebo bupropion; Drug · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 75 Years
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Prostate Cancer
Interventions: Virtual Reality Headset, Aromatherapy Patch, Standard of Care; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older · Male only
Enrollment: 208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Amblyopia
Interventions: Physical Exercise in addition to Patching; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 5 Years to 16 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Glioblastoma
Interventions: Stereotactic Radiosurgery, Nivolumab, Valproate; Radiation · Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Kidney Cancer
Interventions: Perflutren lipid microsphere, Sulfur hexafluoride lipid microspheres; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Metastatic Cancers, Multiple Myeloma, Vertebral Fracture
Interventions: Vertebroplasty, Radiotherapy; Procedure · Radiation
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Breast Cancer
Interventions: Non-contrast DWI, Non-contrast MRI; Device
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 269 participants
Timeline: 2018 – 2029
U.S. locations: 2
States / cities: Portland, Oregon • Seattle, Washington

Conditions: Esophageal Cancer, Precancerous Condition
Interventions: HPPH; Drug
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 8 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2035
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Actinic Keratosis
Interventions: Photodynamic therapy (PDT), Vitamin D3; Drug
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Melanoma
Interventions: MelaFind; Device
Lead sponsor: MELA Sciences, Inc.; Industry
Eligibility: Not listed
Enrollment: 487 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 6
States / cities: Englewood, Colorado • Tallahassee, Florida • Baltimore, Maryland + 3 more

Conditions: Postpartum Bladder Dysfunction, Post-prostatectomy Bladder Dysfunction, Bladder Dysfunction
Interventions: DFree Non-Invasive Bladder Ultrasound, Perifit Kegel Exerciser, Exit interview; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Healthy Adult Participants, Heart Disease, Arrythmia, Cardiac
Interventions: eWave Patch; Device
Lead sponsor: Wearlinq; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New London, North Carolina

Conditions: Tobacco Use Cessation, Alcohol-related Disorders
Interventions: behavioral counseling plus contingency management; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Newington, Connecticut • West Haven, Connecticut

Conditions: Benign Pigmented Lesions
Interventions: GentleMax system; Device
Lead sponsor: Syneron Medical; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Common Bile Duct Neoplasms, Non-Neoplastic Bile Duct Disorder
Interventions: AI model classification, DSOC endoscopist experts' classification; Diagnostic Test
Lead sponsor: Instituto Ecuatoriano de Enfermedades Digestivas; Other
Eligibility: 18 Years to 79 Years
Enrollment: 170 participants
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: New Brunswick, New Jersey • Houston, Texas

Conditions: Opioid-use Disorder, Opioid Use, Opioid Dependence, Opioid Abuse, Medication Assisted Treatment, Infusion Catheter, Wound, Lidopatch, Ambu ACTion, Pregnancy Related, Cesarean Section
Interventions: Lidocaine patch, Ambu ACTion pump, 0.125% bupivacaine at 8cc/hr; Drug · Device
Lead sponsor: WellSpan Health; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: York, Pennsylvania

Conditions: Hypersensitivity
Interventions: Butenafine HCl 1% (BAY1896425); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Fairfield, New Jersey

Conditions: Fertility, Contraception
Interventions: Leuprolide acetate, Estrogen and Progesterone Replacement, Progestin; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years to 40 Years · Female only
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Non-small Cell Lung Cancer (NSCLC)
Interventions: iSABR, 25 Gray in 1 fraction for small peripheral tumors, iSABR, 50 Gray in 4 fractions for medium peripheral tumors, iSABR, 54 Gray in 3 fractions for large peripheral tumors, iSABR, 40 Gray in 4 fractions for small central tumors, iSABR, 50 Gray in 4 fractions for medium central tumors, iSABR, 60 Gray in 8 fractions for large central tumors; Radiation
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2022
U.S. locations: 2
States / cities: Stanford, California • Seattle, Washington

Conditions: Dental Caries in Children, Tooth Erosion, Fluorosis, Dental, Dental Caries
Interventions: indirect- 3D digital scanning; Diagnostic Test
Lead sponsor: Indiana University; Other
Eligibility: 3 Years to 12 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Suicide
Interventions: Transdermal Estradiol, Placebo; Drug · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 20 Years to 40 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acne Vulgaris
Interventions: Triamcinolone delivered via injection assistance device; Device
Lead sponsor: ACOM Labs; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Fremont, California • Boca Raton, Florida • Hollywood, Florida

Search by objective public record fields.

Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis

Comparing Smoking Treatment Programs for Lighter Smokers - 1

Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

Augmenting Patching Treatment for Amblyopia With Physical Exercise

Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer

Non-contrast DWI for Supplemental Screening

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia

Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses

Post-Approval Study of MelaFind

Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physical Therapy Clinics

A Usability Study of a Multi-channel ECG Monitoring Device

Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk

Picosecond Laser for Ttreatment of Benign Pigmented Lesions

Artificial Intelligence for Digital Cholangioscopy Neoplasia Diagnosis

The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis

Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)

Regulation of Cervical Mucus Secretion

Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)

3D Scanning as an Advanced Tool for Identifying Tooth Lesions in Children

Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality

Self-Administered Intralesional Injections for Acne